Incept BioSystems
Latest round
- Series A
Last raised
- Mar 2007
Total raised
- $6.5M
Investors
- 3
About Incept BioSystems
Founded in 2005 and headquartered in Ann Arbor, US, Incept BioSystems specializes in biotechnology solutions targeting critical health challenges.Incept Bio specializes in providing innovative biotechnology solutions aimed at addressing critical health challenges through the development of advanced therapeutics and diagnostic tools. Their core offerings include proprietary biopharmaceuticals designed for targeted treatment of complex diseases, alongside cutting-edge diagnostic platforms that enhance disease detection and monitoring. These products have been engineered to improve patient outcomes by facilitating personalized treatment strategies tailored to the individual needs of patients in various therapeutic areas, including oncology and rare genetic disorders.Incept Bio generates revenue through a structured model that includes direct sales to healthcare institutions and partnerships with research organizations. Revenue streams are established through the sale of their flagship biopharmaceutical products and diagnostic services, which are offered under competitive pricing plans tailored to meet the needs of institutional buyers. The company engages in B2B transactions, providing bulk purchasing options for hospitals and clinics, while also forming strategic alliances with pharmaceutical companies to enhance distribution channels and market reach. Additionally, subscription-based models may be implemented for ongoing access to their diagnostic platforms, ensuring that clients benefit from the latest advancements in technology as they become available.Incept BioSystems is focused on expanding its product lineup with new therapeutics and diagnostic tools aimed for release in upcoming years. They are pursuing market expansion into Europe and Asia by 2015, enhancing their global footprint.
Who invested in Incept BioSystems
3 investors across 2 rounds
See all investors in Incept BioSystems
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Incept BioSystems
Who invested in Incept BioSystems?
Incept BioSystems has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Incept BioSystems raised?
Incept BioSystems has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Incept BioSystems last raise money?
Incept BioSystems's most recent round on record is a Series A, in Mar 2007.
What does Incept BioSystems do?
Founded in 2005 and headquartered in Ann Arbor, US, Incept BioSystems specializes in biotechnology solutions targeting critical health challenges.
Where is Incept BioSystems headquartered?
Incept BioSystems is headquartered in Ann Arbor, US.
Which VCs invest in companies like Incept BioSystems?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Incept BioSystems's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Incept BioSystems? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.